{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:55:07Z","timestamp":1781704507553,"version":"3.54.5"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ogc.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T23:23:25Z","timestamp":1525735405000},"page":"281-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Insights in Peripartum Cardiomyopathy"],"prefix":"10.1016","volume":"45","author":[{"given":"Meredith O.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Briller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith U.","family":"Hibbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2018.02.002_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000441-193708000-00005","article-title":"Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium","volume":"19","author":"Gouley","year":"1937","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/01.CIR.44.5.964","article-title":"Peripartum cardiomyopathy","volume":"44","author":"Demakis","year":"1971","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ogc.2018.02.002_bib3","first-page":"311","article-title":"A\u00a0modified definition for peripartum cardiomyopathy and prognosis based on echocardiography","volume":"94","author":"Hibbard","year":"1999","journal-title":"Obstetrics Gynecol"},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10.1016\/j.ogc.2018.02.002_bib5","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","article-title":"Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation","volume":"111","author":"Elkayam","year":"2005","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ogc.2018.02.002_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AOG.0b013e3181c4ee8c","article-title":"Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004-2006","volume":"115","author":"Kuklina","year":"2010","journal-title":"Obstetrics Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2018.02.002_bib8","first-page":"1326","article-title":"Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997","volume":"102","author":"Whitehead","year":"2003","journal-title":"Obstetrics Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2018.02.002_bib9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.amjcard.2006.01.039","article-title":"Frequency of peripartum cardiomyopathy","volume":"97","author":"Mielniczuk","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ogc.2018.02.002_bib10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","article-title":"Incidence, mortality, and racial differences in peripartum cardiomyopathy","volume":"100","author":"Brar","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/AOG.0b013e318229e6de","article-title":"Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes","volume":"118","author":"Gunderson","year":"2011","journal-title":"Obstetrics Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib12","doi-asserted-by":"crossref","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study","volume":"3","author":"Kolte","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ogc.2018.02.002_bib13","unstructured":"CDC. Severe maternal morbidity in the United States 2017. Available at: www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/pmss.html. Accessed July 25, 2017."},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/AOG.0000000000001981","article-title":"Maternal cardiovascular mortality in Illinois, 2002-2011","volume":"129","author":"Briller","year":"2017","journal-title":"Obstetrics Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/AOG.0000000000000746","article-title":"Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities","volume":"125","author":"Main","year":"2015","journal-title":"Obstetrics Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib16","doi-asserted-by":"crossref","first-page":"379.e1-10","DOI":"10.1016\/j.ajog.2015.05.008","article-title":"Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy","volume":"213","author":"Hameed","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2018.02.002_bib17","first-page":"1","article-title":"Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ogc.2018.02.002_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2008.06.054","article-title":"Aetiology and risk factors of peripartum cardiomyopathy: a systematic review","volume":"131","author":"Ntusi","year":"2009","journal-title":"Int J Cardiol"},{"issue":"4 Pt 2","key":"10.1016\/j.ogc.2018.02.002_bib19","first-page":"H1060","article-title":"Serial study of factors influencing changes in cardiac output during human pregnancy","volume":"256","author":"Robson","year":"1989","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-9149(94)90906-7","article-title":"Incidence of myocarditis in peripartum cardiomyopathy","volume":"74","author":"Rizeq","year":"1994","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mhj.2000.110091","article-title":"Myocarditis and long-term survival in peripartum cardiomyopathy","volume":"140","author":"Felker","year":"2000","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1385\/CRIAI:23:3:301","article-title":"Autoimmune mechanisms as the basis for\u00a0human peripartum cardiomyopathy","volume":"23","author":"Ansari","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCRESAHA.111.249037","article-title":"Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation","volume":"110","author":"Kara","year":"2012","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib24","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3390\/ijms16047644","article-title":"Serum selenium and ceruloplasmin in nigerians with peripartum cardiomyopathy","volume":"16","author":"Karaye","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ogc.2018.02.002_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9378(93)90479-3","article-title":"Peripartum heart failure associated with prolonged tocolytic therapy","volume":"168","author":"Lampert","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jchf.2013.04.011","article-title":"Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy","volume":"1","author":"Kao","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A\u00a0cathepsin D-cleaved 16\u00a0kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"issue":"7398","key":"10.1016\/j.ogc.2018.02.002_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib29","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","article-title":"MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy","volume":"123","author":"Halkein","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"7181","key":"10.1016\/j.ogc.2018.02.002_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ogc.2018.02.002_bib31","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib32","doi-asserted-by":"crossref","first-page":"428.e1-6","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ogc.2018.02.002_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003349","article-title":"Angiogenic imbalance and residual myocardial injury in recovered peripartum cardiomyopathy patients","volume":"9","author":"Goland","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jchf.2016.01.004","article-title":"Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy: results of the multicenter IPAC study","volume":"4","author":"Damp","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2\u20133","key":"10.1016\/j.ogc.2018.02.002_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0167-5273(02)00357-1","article-title":"Mother-daughter peripartum cardiomyopathy","volume":"86","author":"Fett","year":"2002","journal-title":"Int J Cardiol"},{"issue":"20","key":"10.1016\/j.ogc.2018.02.002_bib36","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","article-title":"Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy","volume":"121","author":"van Spaendonck-Zwarts","year":"2010","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ogc.2018.02.002_bib37","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","article-title":"Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy","volume":"121","author":"Morales","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ogc.2018.02.002_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ogc.2018.02.002_bib39","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMc1602671","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCGENETICS.110.959205","article-title":"Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy","volume":"4","author":"Horne","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib41","doi-asserted-by":"crossref","first-page":"e002683","DOI":"10.1161\/CIRCHEARTFAILURE.115.002683","article-title":"GNB3 C825T polymorphism and myocardial recovery in peripartum cardiomyopathy: results of the multicenter investigations of pregnancy-associated cardiomyopathy study","volume":"9","author":"Sheppard","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.ogc.2018.02.002_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.ogc.2018.02.002_bib43","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"62","author":"Bello","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ogc.2018.02.002_bib44","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4065\/80.12.1602","article-title":"Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution","volume":"80","author":"Fett","year":"2005","journal-title":"Mayo Clinic Proc"},{"issue":"16","key":"10.1016\/j.ogc.2018.02.002_bib45","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ogc.2018.02.002_bib46","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ogc.2018.02.002_bib47","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00330-008-1067-x","article-title":"Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging","volume":"18","author":"Mouquet","year":"2008","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib48","article-title":"Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy","volume":"6","author":"Schelbert","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9536","key":"10.1016\/j.ogc.2018.02.002_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","article-title":"Peripartum cardiomyopathy","volume":"368","author":"Sliwa","year":"2006","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ogc.2018.02.002_bib50","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ogc.2018.02.002_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0002-9378(76)90517-2","article-title":"Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes","volume":"126","author":"Ueland","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2018.02.002_bib52","series-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"Briggs","year":"2017"},{"issue":"11","key":"10.1016\/j.ogc.2018.02.002_bib53","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ogc.2018.02.002_bib54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ogc.2018.02.002_bib55","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.110.012781","article-title":"Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions","volume":"123","author":"Cole","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction","volume":"121","author":"Ersboll","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2018.02.002_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2016.04.143","article-title":"Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry","volume":"216","author":"Haghikia","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ogc.2018.02.002_bib58","unstructured":"Amgen C. What is Corlanor? 2016. Available at: https:\/\/www.corlanor.com\/what-is-corlanor-chronichf-treatment\/. Accessed September 30, 2017."},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib59","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jth.13366","article-title":"Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH","volume":"14","author":"Cohen","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib60","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.hrthm.2013.01.008","volume":"10","author":"Russo","year":"2013","journal-title":"Heart Rhythm"},{"issue":"25 Pt A","key":"10.1016\/j.ogc.2018.02.002_bib61","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.jacc.2014.04.014","article-title":"Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use","volume":"63","author":"Pillarisetti","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ogc.2018.02.002_bib62","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.188","article-title":"Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator","volume":"16","author":"Duncker","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"10.1016\/j.ogc.2018.02.002_bib63","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1161\/CIR.0000000000000507","article-title":"Recommendations for the use of mechanical circulatory support: ambulatory and community patient care: a scientific statement from the American Heart Association","volume":"135","author":"Cook","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2010.08.065","article-title":"Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet","volume":"154","author":"Safirstein","year":"2012","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib66","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-84-5-532","article-title":"Galactorrhea-amenorrhea syndromes: etiology and treatment","volume":"84","author":"Spark","year":"1976","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.ogc.2018.02.002_bib67","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","article-title":"Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy","volume":"108","author":"Haghikia","year":"2013","journal-title":"Basic Res Cardiol"},{"issue":"35","key":"10.1016\/j.ogc.2018.02.002_bib69","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"issue":"35","key":"10.1016\/j.ogc.2018.02.002_bib70","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/eurheartj\/ehx428","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD","volume":"38","author":"Arrigo","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0735-1097(99)00161-8","article-title":"Intravenous immune globulin in the therapy of peripartum cardiomyopathy","volume":"34","author":"Bozkurt","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ogc.2018.02.002_bib72","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","article-title":"Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy","volume":"103","author":"McNamara","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","article-title":"The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy","volume":"4","author":"Sliwa","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.ogc.2018.02.002_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00392-010-0279-7","article-title":"Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial","volume":"100","author":"Biteker","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"18","key":"10.1016\/j.ogc.2018.02.002_bib75","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: current management and future perspectives","volume":"36","author":"Hilfiker-Kleiner","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ogc.2018.02.002_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ogc.2010.02.003","article-title":"Update on peripartum cardiomyopathy","volume":"37","author":"Cruz","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib77","first-page":"36","article-title":"Contraception and reproductive counseling in women with peripartum cardiomyopathy","volume":"96","author":"Rosman","year":"2017","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ogc.2018.02.002_bib78","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00005082-200505000-00007","article-title":"The importance and impact of social support on outcomes in patients with heart failure: an overview of the literature","volume":"20","author":"Luttik","year":"2005","journal-title":"J\u00a0Cardiovasc Nurs"},{"issue":"19","key":"10.1016\/j.ogc.2018.02.002_bib79","doi-asserted-by":"crossref","first-page":"e6898","DOI":"10.1097\/MD.0000000000006898","article-title":"Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: a 15-year nationwide population-based study in Asia","volume":"96","author":"Lu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib80","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurjhf\/hfs070","article-title":"Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy","volume":"14","author":"Biteker","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib81","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/AOG.0b013e31826e46a1","article-title":"Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality","volume":"120","author":"Harper","year":"2012","journal-title":"Obstetrics Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cardfail.2013.03.004","article-title":"Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States","volume":"19","author":"Goland","year":"2013","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.ogc.2018.02.002_bib83","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","article-title":"Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women","volume":"2","author":"Irizarry","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib84","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cardfail.2009.03.008","article-title":"Clinical profile and predictors of complications in peripartum cardiomyopathy","volume":"15","author":"Goland","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/heartjnl-2012-302760","article-title":"Predictors of outcome in 176 South African patients with peripartum cardiomyopathy","volume":"99","author":"Blauwet","year":"2013","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ogc.2018.02.002_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002756","article-title":"Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes","volume":"9","author":"Blauwet","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.ogc.2018.02.002_bib87","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1253\/circj.CJ-10-1214","article-title":"Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese nationwide survey of peripartum cardiomyopathy","volume":"75","author":"Kamiya","year":"2011","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib88","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/hrt.2006.087387","article-title":"Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy","volume":"93","author":"Hu","year":"2007","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.ogc.2018.02.002_bib89","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","article-title":"Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy","volume":"344","author":"Elkayam","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2009.10.011","article-title":"Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers","volume":"109","author":"Fett","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"15","key":"10.1016\/j.ogc.2018.02.002_bib91","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacc.2014.07.961","article-title":"Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy","volume":"64","author":"Elkayam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1 Pt 1","key":"10.1016\/j.ogc.2018.02.002_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9378(97)80034-8","article-title":"Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function","volume":"176","author":"Lampert","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2018.02.002_bib93","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/HPC.0b013e3181c42faa","article-title":"Personal commentary: monitoring subsequent pregnancy in recovered peripartum cardiomyopathy mothers","volume":"8","author":"Fett","year":"2009","journal-title":"Crit Pathw Cardiol"},{"issue":"1","key":"10.1016\/j.ogc.2018.02.002_bib94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HPC.0b013e31820b887b","article-title":"Validation of a self-test for early diagnosis of heart failure in peripartum cardiomyopathy","volume":"10","author":"Fett","year":"2011","journal-title":"Crit pathways Cardiol"},{"issue":"9","key":"10.1016\/j.ogc.2018.02.002_bib95","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","article-title":"Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review","volume":"283","author":"Pearson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2018.02.002_bib96","series-title":"Medications and mother\u2019s milk","author":"Hale","year":"2017"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T17:57:05Z","timestamp":1604253425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854518300196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889854518300196"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2018.02.002","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights in Peripartum Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}